Literature DB >> 10630918

Prevention of cerebral palsy in glutaric aciduria type 1 by dietary management.

A A Monavari1, E R Naughten.   

Abstract

AIMS: To study retrospectively the effects of treatment and the clinical outcome in 12 patients with glutaric aciduria type 1; and to compare the outcome in 6 patients diagnosed as a result of family screening with 6 patients who were diagnosed late after symptomatic presentation.
SETTING: The National Centre for Inherited Metabolic Disorders, The Children's Hospital, Dublin, Ireland. RESULT: Four of the 6 children detected on screening are developmentally normal, 1 died, and the remaining 1 has mild mental handicap. All 6 of the late diagnosed symptomatic group suffered dyskinetic cerebral palsy and 5 have died.
CONCLUSION: Experience of 50 patient treatment years has shown that early intensive management can alter the natural history of this rare disorder.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10630918      PMCID: PMC1718171          DOI: 10.1136/adc.82.1.67

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  Glutaric aciduria; a "new" disorder of amino acid metabolism.

Authors:  S I Goodman; S P Markey; P G Moe; B S Miles; C C Teng
Journal:  Biochem Med       Date:  1975-01

2.  Significance of bound glutarate in the diagnosis of glutaric aciduria type I.

Authors:  A Ribes; E Riudor; P Briones; E Christensen; J Campistol; D S Millington
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Glutaric aciduria: inherited deficiency of glutaryl-CoA dehydrogenase activity.

Authors:  S I Goodman; J G Kohlhoff
Journal:  Biochem Med       Date:  1975-06

4.  Glutaryl-coenzyme A dehydrogenase deficiency: a distinct encephalopathy.

Authors:  G F Hoffmann; F K Trefz; P G Barth; H J Böhles; B Biggemann; H J Bremer; E Christensen; M Frosch; F Hanefeld; D H Hunneman
Journal:  Pediatrics       Date:  1991-12       Impact factor: 7.124

5.  A case of glutaric acidemia type I: effect of riboflavin and carnitine.

Authors:  P H Lipkin; C R Roe; S I Goodman; M L Batshaw
Journal:  J Pediatr       Date:  1988-01       Impact factor: 4.406

6.  Improved assay of glutaryl-CoA dehydrogenase in cultured cells and liver: application to glutaric aciduria type I.

Authors:  E Christensen
Journal:  Clin Chim Acta       Date:  1983-03-28       Impact factor: 3.786

Review 7.  Diagnosis and management of glutaric aciduria type I.

Authors:  I Barić; J Zschocke; E Christensen; M Duran; S I Goodman; J V Leonard; E Müller; D H Morton; A Superti-Furga; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

8.  Studies on glutaryl-CoA dehydrogenase in leucocytes, fibroblasts and amniotic fluid cells. The normal enzyme and the mutant form in patients with glutaric aciduria.

Authors:  E Christensen; N J Brandt
Journal:  Clin Chim Acta       Date:  1978-09-01       Impact factor: 3.786

9.  Chronic subdural hematoma, as an initial manifestation of glutaric aciduria type-1.

Authors:  H Osaka; S Kimura; A Nezu; S Yamazaki; K Saitoh; S Yamaguchi
Journal:  Brain Dev       Date:  1993 Mar-Apr       Impact factor: 1.961

10.  Glutaric aciduria type I: a common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster County, Pennsylvania.

Authors:  D H Morton; M J Bennett; L E Seargeant; C A Nichter; R I Kelley
Journal:  Am J Med Genet       Date:  1991-10-01
View more
  19 in total

Review 1.  Glutaric aciduria type 1 and neonatal screening: time to proceed--with caution.

Authors:  Andrea Superti-Furga
Journal:  Eur J Pediatr       Date:  2003-10-25       Impact factor: 3.183

2.  Adult-onset glutaric aciduria type I presenting with white matter abnormalities and subependymal nodules.

Authors:  T M Pierson; Mani Nezhad; Matthew A Tremblay; Richard Lewis; Derek Wong; Noriko Salamon; Nancy Sicotte
Journal:  Neurogenetics       Date:  2015-08-29       Impact factor: 2.660

Review 3.  Emergency treatment in glutaryl-CoA dehydrogenase deficiency.

Authors:  S Kölker; C R Greenberg; M Lindner; E Müller; E R Naughten; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I).

Authors:  S Kölker; E Christensen; J V Leonard; C R Greenberg; A B Burlina; A P Burlina; M Dixon; M Duran; S I Goodman; D M Koeller; E Müller; E R Naughten; E Neumaier-Probst; J G Okun; M Kyllerman; R A Surtees; B Wilcken; G F Hoffmann; P Burgard
Journal:  J Inherit Metab Dis       Date:  2007-01-03       Impact factor: 4.982

Review 5.  Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.

Authors:  Nikolas Boy; Chris Mühlhausen; Esther M Maier; Jana Heringer; Birgit Assmann; Peter Burgard; Marjorie Dixon; Sandra Fleissner; Cheryl R Greenberg; Inga Harting; Georg F Hoffmann; Daniela Karall; David M Koeller; Michael B Krawinkel; Jürgen G Okun; Thomas Opladen; Roland Posset; Katja Sahm; Johannes Zschocke; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2016-11-16       Impact factor: 4.982

6.  Diffusion-weighted MR imaging and MR spectroscopy in glutaric aciduria type 1.

Authors:  K K Oguz; A Ozturk; A Cila
Journal:  Neuroradiology       Date:  2005-03-18       Impact factor: 2.804

7.  Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters.

Authors:  Nikolas Boy; Gisela Haege; Jana Heringer; Birgit Assmann; Chris Mühlhausen; Regina Ensenauer; Esther M Maier; Thomas Lücke; Georg F Hoffmann; Edith Müller; Peter Burgard; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2012-09-13       Impact factor: 4.982

8.  Brain MRI findings as an important diagnostic clue in glutaric aciduria type 1.

Authors:  J Nunes; S Loureiro; S Carvalho; R P Pais; C Alfaiate; A Faria; P Garcia; L Diogo
Journal:  Neuroradiol J       Date:  2013-05-10

9.  Glutaric aciduria type I: outcome in the Republic of Ireland.

Authors:  E R Naughten; P D Mayne; A A Monavari; S I Goodman; G Sulaiman; D T Croke
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

10.  Role of carnitine in disease.

Authors:  Judith L Flanagan; Peter A Simmons; Joseph Vehige; Mark Dp Willcox; Qian Garrett
Journal:  Nutr Metab (Lond)       Date:  2010-04-16       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.